These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24502480)
1. Commentary: is the drug-eluting balloon the answer to the epidemic of restenosis? Owens CD J Endovasc Ther; 2014 Feb; 21(1):22-4. PubMed ID: 24502480 [No Abstract] [Full Text] [Related]
2. Percutaneous transluminal angioplasty with drug-eluting balloons for salvage of infrainguinal bypass grafts. San Norberto EM; Taylor JH; Carrera S; Vaquero C J Endovasc Ther; 2014 Feb; 21(1):12-21. PubMed ID: 24502479 [TBL] [Abstract][Full Text] [Related]
5. Diffuse Cutaneous Manifestations after Drug-Coated Balloon Angioplasty. Chen W; Lee A; Sabat J; DeVito P; Kraemer C; Zhou W Ann Vasc Surg; 2020 Nov; 69():451.e1-451.e4. PubMed ID: 32615205 [TBL] [Abstract][Full Text] [Related]
6. Mortality After Paclitaxel-Coated Device Use in Dialysis Access: A Systematic Review and Meta-Analysis. Dinh K; Limmer AM; Paravastu SCV; Thomas SD; Bennett MH; Holden A; Varcoe RL J Endovasc Ther; 2019 Oct; 26(5):600-612. PubMed ID: 31455140 [No Abstract] [Full Text] [Related]
7. Commentary: treatment of femoropopliteal in-stent restenosis for patients with diabetes: do we have an answer to the DEBATE? Armstrong EJ; Laird JR J Endovasc Ther; 2014 Feb; 21(1):9-11. PubMed ID: 24502478 [No Abstract] [Full Text] [Related]
8. Commentary: drug-coated balloon angioplasty to improve carotid stenting outcomes after postendarterectomy restenosis: fad or an answer to the problem of recurrent restenosis? Del Giudice C; Pellerin O; Gandini R; Sapoval M J Endovasc Ther; 2015 Apr; 22(2):217-9. PubMed ID: 25809365 [No Abstract] [Full Text] [Related]
10. Balloon angioplasty for revision of failing lower extremity bypass grafts. Ali H; Elbadawy A; Saleh M; Hasaballah A J Vasc Surg; 2015 Jul; 62(1):93-100. PubMed ID: 25769387 [TBL] [Abstract][Full Text] [Related]
11. David versus Goliath: the first round. Micari A; Vadalà G JACC Cardiovasc Interv; 2014 Sep; 7(9):1057-9. PubMed ID: 25234680 [No Abstract] [Full Text] [Related]
12. Missing the Forest for the Trees?: Drug-Eluting Balloon Treatment for Infrapopliteal Disease. Tsai TT JACC Cardiovasc Interv; 2015 Oct; 8(12):1623-5. PubMed ID: 26493254 [No Abstract] [Full Text] [Related]
13. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date. Barkat M; Torella F; Antoniou GA Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous revascularization for peripheral arterial disease: paclitaxel saves the day. Mahmud E JACC Cardiovasc Interv; 2013 Mar; 6(3):290-2. PubMed ID: 23517841 [No Abstract] [Full Text] [Related]
15. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828 [TBL] [Abstract][Full Text] [Related]
16. In-stent restenosis management: the best is yet to come. van den Berg JC J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039 [TBL] [Abstract][Full Text] [Related]
17. The THUNDER trial results: clearing the way or ushering the storm? Jaff MR JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):109-10. PubMed ID: 25616823 [No Abstract] [Full Text] [Related]